A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : allo-HSCT

Search Conditions:
Search Keyword : allo-HSCT
Search Method : Exact match.
Research Area:

Abbreviation: allo-HSCT
Appearance Frequency: 2357 time(s)
Long forms: 8

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
allogeneic hematopoietic stem cell transplantation
(2255 times)
(941 times)
GVHD (476 times)
OS (414 times)
AML (266 times)
2001 Resolution of sarcoidosis after allogeneic bone marrow transplantation with donor lymphocyte infusions.
allogeneic HSCT
(53 times)
(21 times)
HSCT (41 times)
auto-HSCT (21 times)
OS (13 times)
2002 Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.
allogeneic hematopoietic SCT
(42 times)
(40 times)
CI (6 times)
aGVHD (5 times)
RIC (5 times)
2008 Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.
allogeneic haematopoietic stem cell
(2 times)
(1 time)
aGVHD (1 time)
cGVHD (1 time)
EFS (1 time)
2007 [JAK3 mRNA level in graft versus host disease patients: a preliminary study].
allogenic HSC transplantation
(2 times)
Allergy and Immunology
(1 time)
ET (1 time)
HSCs (1 time)
MF (1 time)
2015 [Myeloproliferative neoplasms: pathophysiology and therapeutic strategy].
adults with hematological disorders undergoing hematopoietic stem cell transplantation
(1 time)
(1 time)
ADT (1 time)
AdV (1 time)
GVHD (1 time)
2016 Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.
allogeneic HLA-matched siblehematopoietic stem cell transplantation
(1 time)
(1 time)
AML (1 time)
TET2 (1 time)
WT1 (1 time)
2021 Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient.
and, in some, hematopoietic stem cell transplantation
(1 time)
(1 time)
AML (1 time)
CBF (1 time)
EFS (1 time)
2019 Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01.